个性化文献订阅>期刊> Current Opinion in Drug Discovery & Development
 

Cloud computing in pharmaceutical R&D: Business risks and mitigations

  作者 Geiger, K  
  选自 期刊  Current Opinion in Drug Discovery & Development;  卷期  2010年13-3;  页码  279-285  
  关联知识点  
 

[摘要]Cloud computing provides information processing power and business services, delivering these services over the Internet from centrally hosted locations. Major technology corporations aim to supply these services to every sector of the economy. Deploying business processes 'in the cloud' requires special attention to the regulatory and business risks assumed when running on both hardware and software that are outside the direct control of a company. The identification of risks at the correct service level allows a good mitigation strategy to be selected. The pharmaceutical industry can take advantage of existing risk management strategies that have already been tested in the finance and electronic commerce sectors. In this review, the business risks associated with the use of cloud computing are discussed, and mitigations achieved through knowledge from securing services for electronic commerce and from good IT practice are highlighted.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内